Intracranial Aneurysm Clinical Trial
Official title:
Evaluation of Postoperative Cognitive Function, Anxiety, Depression and Quality of Life in Patients With Unruptured Intracranial Aneurysms: a Multi-center Prospective Cohort Study
NCT number | NCT03494608 |
Other study ID # | UIACGF |
Secondary ID | |
Status | Not yet recruiting |
Phase | |
First received | |
Last updated | |
Start date | May 2018 |
Est. completion date | May 2020 |
This prospective single-center cohort study aims to identify the incidence of cognitive dysfunction after unruptured aneurysm operation and explore the influencing factors. The primary end point is the cognitive dysfunction at 6 months after operation.The features of cognitive function, mental status, neurological function recovery, and quality of life of patients with unruptured intracranial aneurysms at different time points would be analyzed.
Status | Not yet recruiting |
Enrollment | 350 |
Est. completion date | May 2020 |
Est. primary completion date | February 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 14 Years and older |
Eligibility |
Inclusion Criteria: 1. At least one imaging (CTA / MRI / DSA) study to confirm unruptured intracranial aneurysms for the patients who would undergo surgical treatment for the first time.; 2. Patients who live independent with minimal care support, mRS score =3 points; 3. Age > 14 years old; 4. Han ethnicity, Right handed, can complete the test; 5. Patient or family agrees to sign informed consent. Exclusion Criteria: 1. Other cerebrovascular diseases,such as ischemic stroke, arteriovenous malformation, etc; 2. With an unexplained subarachnoid hemorrhage; 3. History of Neurological disease surgery; 4. Previous psychiatric and dementia history that cannot communicate with other people; 5. Patients who refused to follow up. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Xuanwu Hospital, Beijing | Tang-Du Hospital, West China Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the Incidence of cognitive dysfunction at 6 months after operation | The Montreal Cognitive Assessment Scale (MoCA) scale contains 8 cognitive domain,11 items and is suitable for assess cognitive function which including: Attention and concentration, executive function, memory, language, visual structure skills, abstract thinking, calculation and orientation.. 1 point for each correct answer. No points if they make any errors. The total score is 30 points. For those who have been educated for 12 years or less and the total score of MoCA is less than 30, one point is added to the total MoCA score. According to the results of MoCA assessment, Patients were divided into two groups: cognitive dysfunction group and cognitive function normal group. MoCA score =26 points suggested normal cognitive function (CN). | the 6th month after operation of the patient inclusion in the study | |
Secondary | the difference in the percentage of patients with HAMA score =14 before operation and 6 months after operation | The Hamilton Anxiety Scale (HAMA) scale contains 14 items and is suitable for the adults with anxiety. Each item is divided into 5 grades evaluated using 0 to 4 scores. The total scores of HAMA scale can reflect patients' anxious condition to some extent. The total scores of less than 7 is regarded as no anxiety, 7 or more possible anxiety, 14 or more definite anxiety, 21 or more marked anxiety, 29 or more severe anxiety. In this study, Anxiety is defined as=14 points. | before operation and the 6th month after operation of the patient inclusion in the study | |
Secondary | the difference in the percentage of patients with HDMA score =14 before operation and 6 months after operation | The Hamilton Depression Scale (HAMD) scale contains 24 items and is suitable for the adults with depression. Each item is divided into 5 grades evaluated using 0 to 4 scores. The total scores of the HAMD scale can reflect patients' depressive condition to some extent. The total scores of less than 8 is regarded as no depression, 8 to 16 mild depression, 17 to 24 moderate depression, and more than 24 severe depression. In this study, Depression is defined as=14 points. | before operation and the 6th month after operation of the patient inclusion in the study | |
Secondary | the tendency of mRS scores and the difference in the percentage of patients with mRS scores 0-3 and 4-6 points before operation, 3 months after operation, and 6 months after operation | The Modified Rankin Scale (mRS) is a valid and clinically relevant instrument that is used to assess recovery (death, disability, and dependence) after stroke and is a commonly used outcome measure in SAH studies. The mRS ranges from 0 (no symptoms) to 6 (death). Unfavourable outcome in survivors is defined as mRS 3-5. | before operation ,the 3th month and the 6th month after operation of the patient inclusion in the study | |
Secondary | the tendency of SF-36 scores before operation, 3 months after operation, and 6 months after operation | 36-item short form health survey(SF-36) | before operation ,the 3th month and the 6th month after operation of the patient inclusion in the study |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04870047 -
Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation
|
N/A | |
Recruiting |
NCT05968053 -
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
|
||
Not yet recruiting |
NCT05665309 -
Interest of Pre-operative Use of 3D Printing for Endovascular Treatment of Unruptured Intracranial Aneurysms With Intrasaccular Flow Disruptor
|
N/A | |
Completed |
NCT02783339 -
Neuroform Atlas Stent for Intracranial Aneurysm Treatment
|
||
Withdrawn |
NCT01194388 -
Axium Coil in Completing Endovascular Aneurysm Surgery Study
|
||
Completed |
NCT00071565 -
Familial Intracranial Aneurysm Study II
|
N/A | |
Recruiting |
NCT05409989 -
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
|
N/A | |
Completed |
NCT03680742 -
Contour Neurovascular System - European Pre-Market Unruptured Aneurysm
|
N/A | |
Completed |
NCT04872842 -
Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on 100 Regional Medical Centers in China and Population Follow-up Study
|
||
Terminated |
NCT02532517 -
Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device
|
N/A | |
Completed |
NCT03663257 -
Study to Evaluate Cerebral AneurysmFlow Results in Occlusion
|
||
Recruiting |
NCT06189950 -
Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE
|
N/A | |
Recruiting |
NCT05608122 -
Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on Regional Medical Centers in China and Population Follow-up Study (Phase Ⅱ)
|
||
Recruiting |
NCT03661463 -
Unruptured Intracranial Aneurysm Aspirin Trial (UIAAT).
|
Phase 2 | |
Completed |
NCT02609867 -
A Feasibility Study to Evaluate the Safety and Effectiveness of Implantation of Flowise Cerebral Flow Diverter (Flowise)
|
N/A | |
Active, not recruiting |
NCT02292017 -
Prospective Packing Density With Target Coils I
|
N/A | |
Active, not recruiting |
NCT01872741 -
Minipterional Versus Pterional Craniotomy
|
N/A | |
Completed |
NCT00993057 -
Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia
|
Early Phase 1 | |
Completed |
NCT00777907 -
Complete Occlusion of Coilable Aneurysms
|
Phase 3 | |
Completed |
NCT00777088 -
Pipeline for Uncoilable or Failed Aneurysms
|
N/A |